论文部分内容阅读
目的:探讨莫沙必利分散片联合艾普拉唑治疗胆汁反流性胃炎的临床疗效。方法:本研究选择2011年1月至2014年6月之间在我院接受治疗的200例胆汁反流性胃炎患者为观察对象,随机将其分为对照组和实验组,两组患者均接受莫沙必利分散片治疗,实验组同时服用艾普拉唑,对照组同时服用奥美拉唑,回顾分析两组观察对象临床疗效。结果:实验组观察对象内镜下疗效和临床疗效均明显优于对照组,两组观察对象临床治疗效果对比具有明显的统计学差异(P<0.05)。结论:莫沙必利分散片联合艾普拉唑是一种较为有效且安全性的临床治疗方法,具有较高的推广应用价值。
Objective: To investigate the clinical efficacy of mosapride dispersible tablets combined with ilaprazole in the treatment of bile reflux gastritis. Methods: In this study, 200 patients with bile reflux gastritis treated in our hospital from January 2011 to June 2014 were randomly divided into control group and experimental group, both groups received Mosapride dispersible tablets treatment, the experimental group taking ilaprazole at the same time, while the control group taking omeprazole, the clinical efficacy of the two groups were retrospectively analyzed. Results: The endoscopic efficacy and clinical efficacy of the experimental group were significantly better than that of the control group. There was significant statistical difference between the two groups in the clinical treatment effect (P <0.05). Conclusion: Mosapride dispersible tablets combined with ilaprazole is a more effective and safe method of clinical treatment, with a high value of popularization and application.